Cognitive abilities and adjustment with gabapentin: Results of a multisite study

Epilepsy Research

Volumn 35, Issue 2, 1999, Pages 109-121

  Dodrill, Carl B ^a,b   Arnett, John L ^c   Hayes, Aileen G ^d   Garofalo, Elizabeth A ^d   Greeley, Christina A ^d   Greiner, Martha J ^d   Pierce, Mark W ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

^d NONE

Author keywords

Adjustment; Cognitive abilities; Gabapentin

Indexed keywords

GABAPENTIN; PLACEBO; VIGABATRIN;

ADJUSTMENT; ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; COMPLEX PARTIAL SEIZURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMOTION; FEMALE; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ACETIC ACIDS; ADULT; AMINES; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; EPILEPSY, COMPLEX PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 0033015431     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00006-6     Document Type: Article

References (26)

1. Anhut H., Ashman P., Feuerstein T.J., Sauermann W., Saunders M., Schmidt B. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia. 35:1994;795-801.
2. Baulac M., Cavalcanti D., Semah F., Arzimanoglou A., Portal J.J. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. Seizure. 7:1998;55-62.
3. Benton A.L. Revised Visual Retention Test: Clinical and Experimental Applications. 4th ed:1974;Psychological Corporation, New York.
4. Benton A.L., Hamsher K.deS. Multilingual Aphasia Examination: Manual of Instruction. 1983;AJA Associates, Iowa City.
5. Beydoun A., Fisher J., Labar D.R., Harden C., Cantrell D., Uthman B.M., Sackellares J.C., Abou-Khalil B., Ramsay R.E., Hayes A., Greiner M., Garofalo E., Pierce M. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. Neurology. 49:1997;746-752.
6. Beydoun A., Fakhoury T., Nasreddine W., Abou-Khalil B. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Epilepsia. 39:1998;188-193.
7. Bruni J. Outcome evaluation of gabapentin as add-on therapy for partial seizures. Can. J. Neurol. Sci. 25:1998;134-140.
8. Chadwick D.W., Anhut H., Greiner M.J., Alexander J., Murray G.H., Garofalo E.A., Pierce M.W. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology. 51:1998;1282-1288.
9. Dimond K.R., Pande A.C., Lamoreaux L., Pierce M.W. Effect of gabapentin (Neurontin®) on mood and well-being in patients with epilepsy. Prog. Neuro-Psychopharmcol. Biol. Psychiatry. 20:1996;407-417.
10. Dodrill C.B. A neuropsychological battery for epilepsy. Epilepsia. 19:1978;611-623.
11. Dodrill C.B. An economical method for the evaluation of intelligence in adults. J. Consult. Clin. Psychol. 49:1981;668-673.
12. Dodrill C.B. Behavioral effects of antiepileptic drugs. Smith D., Treiman D., Trimble N.R. Neurobehavioral Problems in Epilepsy: Advances in Neurology. 55:1991;213-224 Raven Press, New York.
13. Dodrill C.B., Batzel L.W., Queisser H., Temkin N.R. An objective method for the assessment of psychological and social problems among epileptics. Epilepsia. 21:1980;123-135.
14. Dodrill C.B., Wilensky A.J., Ojemann L.M., Temkin N.R., Shellenberger K., Wallace J. Neuropsychological, mood, and psychosocial effects of gabapentin. Epilepsia. 33(Suppl. 3):1992;117-118.
15. Dodrill C.B., Arnett J.L., Sommerville K.W., Sussman N.M. Evaluation of the effects of vigabatrin (Sabril®) upon cognitive abilities and quality of life in epilepsy. Neurology. 43:1993;2501-2507.
16. Dodrill C.B., Arnett J.L., Sommerville K.W., Sussman N.M. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia. 36:1995;164-173.
17. Dodrill C.B., Arnett J.L., Shu V., Pixton G.C., Lenz G.T., Sommerville K.W. Effects of tiagabine monotherapy on abilities, adjustment, and mood. Epilepsia. 39:1998;33-42.
18. Gabapentin in partial epilepsy. Lancet. 335:1990;1114-1117.
19. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology. 43:1993;2292-2298.
20. Leach J.P., Girvan J., Paul A., Brodie M.J. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J. Neurol. Neurosurg. Psychiatry. 62:1997;372-376.
21. McNair D.M., Lorr M., Droppleman L.F. Profile of Mood States: Manual. 1981;Educational and Industrial Testing Service, San Diego.
22. Rey A. L'examen Clinique en Psychologie. 1964;Presses Universitaries de France, Paris.
23. Smith A. Symbol Digit Modalities Test: Manual. 1984;Western Psychological Services, Los Angeles.
24. Winer B.J. Statistical Principles in Experimental Design. 2nd ed:1971;McGraw-Hill, New York.
25. Wolf S.M., Shinnar S., Kang H., Gil K.B., Moshé S.L. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia. 36:1995;1203-1205.
26. Wonderlic E.F. Wonderlic Personnel Test: Manual. 1977;Wonderlic, Northfield, IL.